603301.SH
振德医疗
SSE · Healthcare · Medical - Instruments & Supplies · CN
CNY 82.29
+0.57%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 4.3B | 4.3B | 4.3B | 4.1B | 6.1B |
| Cost of Revenue | 2.9B | 2.9B | 2.8B | 2.7B | 4.0B |
| Gross Profit | 1.5B | 1.5B | 1.5B | 1.4B | 2.1B |
| Operating Expenses | |||||
| R&D Expense | 139.6M | 142.4M | 135.5M | 138.9M | 227.0M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 569.1M | 563.2M | 521.6M | 513.2M | 507.3M |
| Selling & Marketing Expense | 364.8M | 362.8M | 368.6M | 381.3M | 477.0M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 1.2B | 1.1B | 1.0B | 1.0B | 1.3B |
| Cost and Expenses | 4.0B | 4.0B | 3.9B | 3.7B | 5.2B |
| Operating Income (EBIT) | 333.0M | 328.3M | 491.8M | 225.9M | 812.8M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 329.1M | 324.8M | 475.5M | 218.9M | 801.7M |
| Income Tax Expense | 56.8M | 57.7M | 78.2M | 5.5M | 100.0M |
| Bottom Line | |||||
| Net Income | 264.0M | 260.8M | 385.2M | 198.4M | 679.9M |
| Earnings from Cont. Ops | 272.3M | 267.1M | 397.2M | 213.4M | 701.8M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 264.0M | 260.8M | 385.2M | 198.4M | 679.9M |
| Per Share | |||||
| Basic EPS | CN¥0.99 | CN¥0.99 | CN¥1.45 | CN¥0.74 | CN¥2.87 |
| Diluted EPS | CN¥0.99 | CN¥0.99 | CN¥1.45 | CN¥0.74 | CN¥2.87 |
| Revenue Per Share | CN¥15.94 | CN¥16.43 | CN¥16.05 | CN¥15.39 | CN¥25.91 |
| Shares | |||||
| Basic Shares Outstanding | 272.2M | 263.5M | 265.6M | 268.1M | 236.9M |
| Diluted Shares Outstanding | 272.2M | 263.5M | 265.6M | 268.1M | 236.9M |
| Profitability Metrics | |||||
| EBITDA | — | 627.2M | 739.6M | 470.2M | 999.2M |
| D&A | — | 298.8M | 247.8M | 244.3M | 186.4M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026